MENU
+Compare
ACB
Stock ticker: NASDAQ
AS OF
Feb 3 closing price
Price
$4.06
Change
-$2.08 (-33.88%)
Capitalization
229.59M

ACB Aurora Cannabis Forecast, Technical & Fundamental Analysis

Aurora Cannabis Inc headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard... Show more

ACB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ACB with price predictions
Feb 02, 2026

Momentum Indicator for ACB turns negative, indicating new downward trend

ACB saw its Momentum Indicator move below the 0 level on January 29, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 90 similar instances where the indicator turned negative. In of the 90 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for ACB turned negative on February 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

The 10-day moving average for ACB crossed bearishly below the 50-day moving average on January 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ACB entered a downward trend on January 29, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ACB advanced for three days, in of 231 cases, the price rose further within the following month. The odds of a continued upward trend are .

ACB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.592) is normal, around the industry mean (29.772). P/E Ratio (19.440) is within average values for comparable stocks, (74.035). ACB's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.041). ACB has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.029). P/S Ratio (0.845) is also within normal values, averaging (112.501).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ACB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
ACB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ACB is expected to report earnings to fall 125.97% to 16 cents per share on February 04

Aurora Cannabis ACB Stock Earnings Reports
Q4'25
Est.
$0.17
Q3'25
Missed
by $0.68
Q2'25
Missed
by $0.03
Q1'25
Missed
by $0.01
Q4'24
Beat
by $0.39
The last earnings report on November 05 showed earnings per share of -64 cents, missing the estimate of 3 cents. With 1.70M shares outstanding, the current market capitalization sits at 229.59M.
A.I. Advisor
published General Information

General Information

a licensed producer of medical marijuana in Canada

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
3498 63 Avenue
Phone
+1 855 279-4652
Employees
1130
Web
https://www.auroramj.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EUUNF0.130.02
+14.25%
Azarga Metals Corporation
BIRDF22.950.75
+3.38%
Bird Construction Inc.
TLGPY17.220.04
+0.23%
Telstra Group Limited
GEDSF22.29N/A
N/A
Gedeon Richter Ltd
BIOYF9.18-0.12
-1.29%
BioSyent Inc.

ACB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ACB has been loosely correlated with CGC. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if ACB jumps, then CGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACB
1D Price
Change %
ACB100%
-3.45%
CGC - ACB
66%
Loosely correlated
N/A
SNDL - ACB
65%
Loosely correlated
-0.65%
OGI - ACB
64%
Loosely correlated
+0.67%
TLRY - ACB
63%
Loosely correlated
-0.27%
CRON - ACB
61%
Loosely correlated
N/A
More

Groups containing ACB

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACB
1D Price
Change %
ACB100%
-3.45%
ACB
(2 stocks)
97%
Closely correlated
+5.46%
Pharmaceuticals: Generic
(214 stocks)
37%
Loosely correlated
+48.62%